#1
What do we mean by "new approach methodologies"?
01:14
#2
Why are new approach methods becoming so important in terms of chemical safety assessments?
02:20
#3
What does the Commission's roadmap for phasing out animal testing aim to achieve?
03:28
#4
What is the level of ambition for the Commission roadmap?
04:37
#5
Intervention from Georg Streck, European Commission on the roadmap to phase out animal testing
06:19
#6
What does the Commission roadmap to phase out animal testing mean for ECHA in practice?
07:40
#7
How work on new approach methodologies are addressed at international level
09:18
#8
How do new approach methodologies affect companies? Intervention from Katia Lacasse, Cefic
10:13
#9
Who carries out research on new approach methodologies for regulatory risk assessment?
14:03
#10
What are most tangible examples of progress in relation to new approach methodologies that ECHA can point to?
15:23
#11
The role of collaboration in advancing new approach methodologies: Intervention from Gavin Maxwell, EPAA.
16:49
#12
ECHA's collaborative platform on alternatives to animal testing: why is the platform needed?
18:29
#13
What can the platform for alternatives to animal testing do to advance the use of new approach methods to specific regulatory use cases?
20:33
#14
Outcomes from the first meeting of the platform for alternatives to animal testing.
21:40
#15
Animal welfare expectation for new approach methods: Intervention from Julia Baines, PETA.
22:45
#16
Expectations from the human health and environment perspective for new approach methods: Sandra Jen, HEAL
23:56
#17
How can ECHA help bring expectations from civil society in a practical regulatory setting?
25:10
#18
What are the biggest misconceptions for how quickly animal tests can be phased out?
26:24
#19
Can new approach methods help address exposure to several chemicals from different sources, the so called "cocktail effect"?
29:17
Moving away from animal testing: how new methods can support chemical safety
The European Commission published its roadmap for phasing out animal testing on 1 June 2026, and the first meeting of ECHA’s Collaborative Platform on Alternatives to Animal Testing has now taken place.
In this episode, we explore what these developments mean for regulators, researchers and industry. Tomasz Sobanski from ECHA explains how new approach methodologies (NAMs) are moving from research into regulatory use, and why the transition requires more than replacing individual tests.
The discussion looks at how the EU roadmap is expected to drive implementation across legislation, and how ECHA contributes through scientific and regulatory expertise, international cooperation and the collaborative platform.
The episode features perspectives from the EPAA, PETA and HEAL on regulatory acceptance, confidence-building, animal welfare, and maintaining a high level of protection for human health and the environment.
Useful links
ECHA convenes first meeting of its collaborative platform on alternatives to animal testing
ECHA supports EU roadmap for alternatives to animal testing with new collaborative platform
Roadmap towards phasing out animal testing and related materials
**************
Follow us on:
Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Powered by Ausha 🚀